News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Carter Todd Alfred
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 5,500 shares
@ $10.8, valued at
$59.4k
|
|
| 07/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/05/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 5,000 shares
@ $11.41, valued at
$57.1k
Exercised 5,000 options to buy
@ $2.85, valued at
$14.3k
|
|
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/22/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 2,193 shares
@ $7.76, valued at
$17k
|
|
| 02/22/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 34,000 shares
@ $0
Sold 738 shares
@ $7.45, valued at
$5.5k
Granted 68,000 options to buy
@ $7.43, valued at
$505.2k
|
|
| 01/19/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 706 shares
@ $9.57, valued at
$6.8k
Sold 400 shares
@ $10.34, valued at
$4.1k
|
|
| 01/10/2023 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 388 shares
@ $5.17, valued at
$2k
Sold 388 shares
@ $6.41, valued at
$2.5k
|
|
| 09/21/2022 |
4
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 165,000 options to buy
@ $6.18, valued at
$1M
|
|
| 09/21/2022 |
3
| Carter Todd Alfred (Chief Scientific Officer) has filed a Form 3 on Voyager Therapeutics, Inc. |
|
|